Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 177

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine

Open access
Ogino, Shuji, Nishihara, Reiko, VanderWeele, Tyler J., Wang, Molin, Nishi, Akihiro, Lochhead, Paul, Qian, Zhi Rong, Zhang, Xuehong, Wu, Kana, Nan, Hongmei, Yoshida, Kazuki, Milner, Danny A., Chan, Andrew T., Field, Alison E., Camargo, Carlos A., Williams, Michelle A., Giovannucci, Edward L. · 2016 · Epidemiology

Abstract

Molecular pathology diagnostics to subclassify diseases based on pathogenesis are increasingly common in clinical translational medicine. Molecular pathological epidemiology (MPE) is an integrative transdisciplinary science based on the unique disease principle and the disease continuum theory. While it has been most commonly applied to research on breast, lung, and colorectal cancers, MPE can investigate etiologic heterogeneity in non-neoplastic diseases, such as cardiovascular diseases, obesity, diabetes mellitus, drug toxicity, and immunity-related and infectious diseases. This science can enhance causal inference by linking putative etiologic factors to specific molecular biomarkers as outcomes. Technological advances increasingly enable analyses of various -omics, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, metagenomics, microbiome, immunomics, interactomics, etc. Challenges in MPE include sample size limitations (depending on availability of biospecimens or biomedical/radiological imaging), need for rigorous validation of molecular assays and study findings, and paucities of interdisciplinary experts, education programs, international forums, and standardized guidelines. To address these challenges, there are ongoing efforts such as multidisciplinary consortium pooling projects, the International Molecular Pathological Epidemiology Meeting Series, and the Strengthening the Reporting of Observational Studies in Epidemiology-MPE guideline project. Efforts should be made to build biorepository and biobank networks, and worldwide population-based MPE databases. These activities match with the purposes of the Big Data to Knowledge (BD2K), Genetic Associations and Mechanisms in Oncology (GAME-ON), and Precision Medicine Initiatives of the United States National Institute of Health. Given advances in biotechnology, bioinformatics, and computational/systems biology, there are wide open opportunities in MPE to contribute to public health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/ede.0000000000000471

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 93

  1. Ogino, 2012, Expert Rev Mol Diagn, 12, 621, 10.1586/erm.12.46 · DOI · Paper page
  2. Ogino, 2010, J Natl Cancer Inst, 102, 365, 10.1093/jnci/djq031 · DOI · Paper page
  3. Ogino, 2011, Gut, 60, 397, 10.1136/gut.2010.217182 · DOI · Paper page
  4. Ogino, 2011, Nat Rev Clin Oncol, 8, 711, 10.1038/nrclinonc.2011.122 · DOI · Paper page
  5. Kuller, 2013, Am J Epidemiol, 178, 1350, 10.1093/aje/kwt239 · doi:10.1093/aje/kwt239
  6. Ogino, 2013, Cancer Prev Res (Phila, 6, CN06
  7. Epplein, 2014, Cancer Epidemiol Biomarkers Prev, 23, 2613, 10.1158/1055-9965.EPI-14-0848 · DOI
  8. Curtin, 2011, Patholog Res Int, 2011, 902674
  9. Hughes, 2011, PLoS One, 6, e18571, 10.1371/journal.pone.0018571 · DOI
  10. Jacobs, 2012, Curr Opin Pharmacol, 12, 690, 10.1016/j.coph.2012.07.010 · DOI
  11. Hughes, 2012, Biochim Biophys Acta, 1825, 77
  12. Iwagami, 2012, Ann Surg Oncol, 19, 2726, 10.1245/s10434-011-2176-3 · DOI
  13. Limburg, 2012, Cancer Epidemiol Biomarkers Prev, 21, 681, 10.1158/1055-9965.EPI-11-1168 · doi:10.1158/1055-9965.epi-11-1168
  14. Hughes, 2012, Int J Epidemiol, 41, 1060, 10.1093/ije/dys055 · DOI
  15. Ku, 2012, Mod Pathol, 25, 1055, 10.1038/modpathol.2012.62 · DOI
  16. Rex, 2012, Am J Gastroenterol, 107, 1315, 10.1038/ajg.2012.161 · DOI · Paper page
  17. Koshiol, 2012, Ann Epidemiol, 22, 520, 10.1016/j.annepidem.2012.03.001 · DOI
  18. Gay, 2012, J Pathol, 228, 405, 10.1002/path.4085 · DOI
  19. Galon, 2012, J Transl Med, 10, 205, 10.1186/1479-5876-10-205 · DOI · Paper page
  20. Chia, 2012, Nat Rev Clin Oncol, 9, 561, 10.1038/nrclinonc.2012.137 · DOI
  21. Spitz, 2012, Cancer Discov, 2, 1087, 10.1158/2159-8290.CD-12-0424 · DOI
  22. Shanmuganathan, 2013, J Mol Diagn, 15, 17, 10.1016/j.jmoldx.2012.06.007 · DOI
  23. Rosty, 2013, Mod Pathol, 26, 825, 10.1038/modpathol.2012.240 · DOI · Paper page
  24. Weijenberg, 2013, Curr Nutr Rep, 2, 19, 10.1007/s13668-012-0038-7 · DOI
  25. Buchanan, 2013, Cancer Epidemiol Biomarkers Prev, 22, 917, 10.1158/1055-9965.EPI-12-1211 · doi:10.1158/1055-9965.epi-12-1211
  26. Burnett-Hartman, 2013, Cancer Res, 73, 2863, 10.1158/0008-5472.CAN-12-3462 · DOI
  27. Alvarez, 2013, World J Gastroenterol, 19, 3043, 10.3748/wjg.v19.i20.3043 · DOI
  28. Hagland, 2013, Dig Surg, 30, 12, 10.1159/000347166 · DOI
  29. Zaidi, 2013, Prog Lipid Res, 52, 585, 10.1016/j.plipres.2013.08.005 · DOI · Paper page
  30. Abbenhardt, 2013, Int J Mol Epidemiol Genet, 4, 140
  31. Hughes, 2013, Cancer Res, 73, 5858, 10.1158/0008-5472.CAN-12-4306 · DOI · Paper page
  32. Bae, 2013, Br J Cancer, 109, 1004, 10.1038/bjc.2013.430 · DOI
  33. Amirian, 2013, Infect Agent Cancer, 8, 42, 10.1186/1750-9378-8-42 · DOI
  34. Hoffmeister, 2013, Cancer Epidemiol Biomarkers Prev, 22, 2303, 10.1158/1055-9965.EPI-13-0239 · DOI
  35. Araújo, 2013, Pathol Res Pract, 209, 753, 10.1016/j.prp.2013.08.007 · DOI
  36. Esterhuyse, 2013, Expert Rev Mol Diagn, 13, 625, 10.1586/14737159.2013.811897 · DOI
  37. Hagland, 2015, Cancer Lett, 356, 273, 10.1016/j.canlet.2014.02.026 · DOI
  38. Shaheen, 2014, Am J Gastroenterol, 109, 345, 10.1038/ajg.2014.35 · DOI
  39. Brändstedt, 2014, BMC Cancer, 14, 371, 10.1186/1471-2407-14-371 · DOI
  40. Coppedè, 2014, Expert Rev Gastroenterol Hepatol, 8, 935, 10.1586/17474124.2014.924397 · DOI
  41. Bishehsari, 2014, World J Gastroenterol, 20, 6055, 10.3748/wjg.v20.i20.6055 · DOI · Paper page
  42. Cross, 2014, Cancer, 120, 3049, 10.1002/cncr.28799 · DOI
  43. Simons, 2014, Cancer Epidemiol Biomarkers Prev, 23, 1852, 10.1158/1055-9965.EPI-13-1285 · DOI
  44. Haque, 2014, Dig Dis Sci, 59, 2874, 10.1007/s10620-014-3277-1 · DOI
  45. Ryan, 2014, Cancer Epidemiol, 38, 583, 10.1016/j.canep.2014.07.003 · DOI
  46. Huser, 2014, Pharmgenomics Pers Med, 7, 275
  47. Wennersten, 2014, Diagn Pathol, 9, 189, 10.1186/s13000-014-0189-5 · DOI
  48. Mikeska, 2014, Genes (Basel, 5, 821, 10.3390/genes5030821 · DOI · Paper page
  49. Campbell, 2014, Cancer Epidemiol Biomarkers Prev, 23, 2694, 10.1158/1055-9965.EPI-14-0541 · doi:10.1158/1055-9965.epi-14-0541
  50. Witvliet, 2014, Austin J Public Health Epidemiol, 1, id1012
  51. Li, 2015, Gut, 64, 1419, 10.1136/gutjnl-2014-308260 · DOI
  52. Wild, 2015, J Natl Cancer Inst, 107, 353, 10.1093/jnci/dju353 · DOI
  53. Caiazza, 2015, Front Oncol, 5, 19, 10.3389/fonc.2015.00019 · DOI · Paper page
  54. Ng, 2015, Int J Mol Sci, 16, 2472, 10.3390/ijms16022472 · DOI · Paper page
  55. Tillmans, 2015, Cancer Epidemiol Biomarkers Prev, 24, 713, 10.1158/1055-9965.EPI-14-0756 · doi:10.1158/1055-9965.epi-14-0756
  56. Cisyk, 2015, Neoplasia, 17, 306, 10.1016/j.neo.2015.02.001 · DOI
  57. Weisenberger, 2015, Cancer Epidemiol Biomarkers Prev, 24, 512, 10.1158/1055-9965.EPI-14-1161 · DOI
  58. Gao, 2015, Austin J Gastroenterol, 2, 1040
  59. Szylberg, 2015, Gastroenterol Res Pract, 2015, 573814, 10.1155/2015/573814 · DOI
  60. Wong, 2015, Expert Rev Anticancer Ther, 15, 639, 10.1586/14737140.2015.1038248 · DOI
  61. Begg, 2015, Cancer Med, 4, 1432, 10.1002/cam4.456 · DOI
  62. Campbell, 2015, Cancer Epidemiol Biomarkers Prev, 24, 1229, 10.1158/1055-9965.EPI-15-0094 · DOI
  63. Mehta, 2015, Anal Cell Pathol (Amst, 2015, 367837
  64. Nishi, 2015, Am J Prev Med, 48, 116, 10.1016/j.amepre.2014.09.031 · DOI
  65. Ogino, 2015, Cancer Causes Control, 26, 959, 10.1007/s10552-015-0596-2 · DOI
  66. Ogino, 2012, Am J Epidemiol, 176, 659, 10.1093/aje/kws226 · DOI
  67. Ogino, 2013, Mod Pathol, 26, 465, 10.1038/modpathol.2012.214 · DOI · Paper page
  68. Suzuki, 2014, Biochem Biophys Res Commun, 455, 35, 10.1016/j.bbrc.2014.07.007 · DOI
  69. Lin, 2014, Curr Colorectal Cancer Rep, 10, 94, 10.1007/s11888-014-0208-7 · DOI
  70. Febbo, 2011, J Natl Compr Canc Netw, 9, S1, 10.6004/jnccn.2011.0137 · DOI · Paper page
  71. Nosho, 2009, Gastroenterology, 137, 1609, 10.1053/j.gastro.2009.08.002 · DOI · Paper page
  72. Song, 2016, Gut, 65, 296, 10.1136/gutjnl-2014-308852 · DOI
  73. Chatterjee, 2010, Biometrika, 97, 683, 10.1093/biomet/asq036 · doi:10.1093/biomet/asq036
  74. Rosner, 2013, Am J Epidemiol, 178, 296, 10.1093/aje/kws457 · DOI
  75. Wang, 2015, Am J Epidemiol, 182, 263, 10.1093/aje/kwv040 · DOI
  76. Ogino, 2012, Int J Epidemiol, 41, 1072, 10.1093/ije/dys076 · DOI
  77. Field, 2013, JAMA, 310, 2147, 10.1001/jama.2013.281501 · DOI
  78. Yamauchi, 2012, Gut, 61, 847, 10.1136/gutjnl-2011-300865 · DOI · Paper page
  79. Yamauchi, 2012, Gut, 61, 794, 10.1136/gutjnl-2012-302014 · DOI · Paper page
  80. Mima, 2015, JAMA Oncol, 1, 653, 10.1001/jamaoncol.2015.1377 · DOI · Paper page
  81. Ogino, 2014, Oncogene, 33, 2949, 10.1038/onc.2013.244 · DOI
  82. Ikramuddin, 2013, JAMA, 310, 2401, 10.1001/jama.2013.280927 · DOI
  83. van Winkel, 2015, Epidemiol Psychiatr Sci, 24, 6, 10.1017/S2045796014000559 · DOI
  84. Ogino, 2008, J Mol Diagn, 10, 13, 10.2353/jmoldx.2008.070082 · DOI · Paper page
  85. Lochhead, 2014, Am J Gastroenterol, 109, 1205, 10.1038/ajg.2014.153 · DOI
  86. Liao, 2012, N Engl J Med, 367, 1596, 10.1056/NEJMoa1207756 · DOI · Paper page
  87. Domingo, 2013, J Clin Oncol, 31, 4297, 10.1200/JCO.2013.50.0322 · DOI · Paper page
  88. Fink, 2014, Sci Transl Med, 6, 233re2, 10.1126/scitranslmed.3008481 · DOI
  89. Chan, 2007, N Engl J Med, 356, 2131, 10.1056/NEJMoa067208 · DOI · Paper page
  90. Chan, 2009, JAMA, 302, 649, 10.1001/jama.2009.1112 · DOI · Paper page
  91. Tougeron, 2014, Clin Cancer Res, 20, 1087, 10.1158/1078-0432.CCR-13-2563 · DOI
  92. Ng, 2011, J Natl Cancer Inst, 103, 1540, 10.1093/jnci/djr307 · DOI
  93. Lee, 2011, Cancer Prev Res (Phila, 4, 1808, 10.1158/1940-6207.CAPR-11-0113 · DOI

Cited by

See all 177

Metadata

Authors
Ogino, S., Nishihara, R., VanderWeele, T. J., Wang, M., Nishi, A., Lochhead, P., Qian, Z. R., Zhang, X., Wu, K., Nan, H., Yoshida, K., Milner, D. A., Chan, A. T., Field, A. E., Camargo, C. A., Williams, M. A., & Giovannucci, E. L.
Venue
Epidemiology
Published
2016-07
Volume
27
Issue
4
Pages
602-611
ISSN
1044-3983 (ISSN-L)
OpenAlex
W2291499494
Cited by
177
References
5
FWCI
13.71
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. https://app.cochat.ai/papers/10.1097/ede.0000000000000471
The paper
Ogino, S., Nishihara, R., VanderWeele, T. J., Wang, M., Nishi, A., Lochhead, P., Qian, Z. R., Zhang, X., Wu, K., Nan, H., Yoshida, K., Milner, D. A., Chan, A. T., Field, A. E., Camargo, C. A., Williams, M. A., & Giovannucci, E. L. (2016). Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. Epidemiology. https://doi.org/10.1097/ede.0000000000000471

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.